Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (3631)	12/14/2005 4:22:34 PM
From: FiloF	Read Replies (1) \| Respond to of 12215

$22.50 per share. Closed at $14.65 today. Dang. Missed that one.

To: scaram(o)uche who wrote (3631)	12/14/2005 5:13:47 PM
From: Ward Knutson	Read Replies (1) \| Respond to of 12215

"Sell the ABGENIX...bottom-tier biotech..." - James Cramer 11/1/2005 ABGX share price $8 I repeat, he speaks (with implied insight) on too many subjects and stocks that he knows ABSOLUTELY NOTHING about.

To: scaram(o)uche who wrote (3631)	12/15/2005 11:42:32 AM
From: scaram(o)uche	Respond to of 12215

>> abgx munched << Nigel mentioned CAT and morphosys. Also DYAX or XOMA? The amev deal gains yet another chunk of credibility ground..... so many moves seem to be going "biological". Didn't hold any ABGX or MEDX, but scalped a boat load of MEDX..... somebody had an ill-placed chunk hanging out at 10.50 after-hours yesterday....... strange that there were so many shares sitting there, capping price into the abgx news. Placed bet that it was something arranged without knowledge of the breaking news.